Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ID: DRG0JNGDA)
| ADC Name |
WO2023173132A1 ADC-4
|
|||||
|---|---|---|---|---|---|---|
| Synonyms |
ADC-4
Click to Show/Hide
|
|||||
| Organization |
REGENERON PHARMACEUTICALS, INC.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Structure |
|
|||||
| Antibody Name |
lsotype control mAb3
|
Antibody Info | Antigen Name |
Undisclosed
|
||
| Payload Name |
P9
|
Payload Info | ||||
| Linker Name |
DIBAC-suC-PEG8
|
Linker Info | ||||
| Conjugate Type |
site-specific conjugation
|
|||||
| Combination Type |
DIBAC-suC-PEG8-P9
|
|||||